Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8544)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol 2015; 21(32): 9566-9576 [PMID: 26327764 DOI: 10.3748/wjg.v21.i32.9566] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9566.htm |
| Number | Citing Articles |
| 1 |
Dongxiao Meng, Zhen Li, Guangchuan Wang, Liping Ling, Ying Wu, Chunqing Zhang. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomedicine & Pharmacotherapy 2018; 108: 1617 doi: 10.1016/j.biopha.2018.10.005
|
| 2 |
Liping Ling, Guangqi Li, Guangchuan Wang, Dongxiao Meng, Zhen Li, Chunqing Zhang. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis . Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10401
|
| 3 |
Rongrong Zhu, Zhaoqi Wang, Peng Liang, Xiaolie He, Xizhen Zhuang, Ruiqi Huang, Mei Wang, Qigang Wang, Yechang Qian, Shilong Wang. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO2@LDH for anti-neuroblastoma therapy. Acta Biomaterialia 2017; 63: 163 doi: 10.1016/j.actbio.2017.09.009
|
| 4 |
Maya Adachi, Mai Watanabe, Yasutaka Kurata, Yumiko Inoue, Tomomi Notsu, Kenshiro Yamamoto, Hiromu Horie, Shogo Tanno, Maki Morita, Junichiro Miake, Toshihiro Hamada, Masanari Kuwabara, Naoe Nakasone, Haruaki Ninomiya, Motokazu Tsuneto, Yasuaki Shirayoshi, Akio Yoshida, Motonobu Nishimura, Kazuhiro Yamamoto, Ichiro Hisatome. β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction. Circulation Journal 2019; 83(11): 2282 doi: 10.1253/circj.CJ-19-0261
|
| 5 |
Mariia Zadorozhna, Sante Di Gioia, Massimo Conese, Domenica Mangieri. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Molecular Biology Reports 2020; 47(3): 2279 doi: 10.1007/s11033-020-05290-0
|
| 6 |
Wen-Chin Chiu, Tzeon-Jye Chiou, Meng-Ju Chung, An-Na Chiang, Rudolf Kirchmair. β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase. PLOS ONE 2016; 11(8): e0161950 doi: 10.1371/journal.pone.0161950
|
| 7 |
Ali Mahmoudi, Stephen L. Atkin, Tannaz Jamialahmadi, Maciej Banach, Amirhossein Sahebkar. Effect of Curcumin on Attenuation of Liver Cirrhosis via Genes/Proteins and Pathways: A System Pharmacology Study. Nutrients 2022; 14(20): 4344 doi: 10.3390/nu14204344
|
| 8 |
Yanquan Han, Lingyu Pan, Shan Ran, Yan Song, Fang‑Fang Sun, Yong‑Zhong Wang, Yan Hong. Rhizoma�Paridis saponins ameliorates hepatic fibrosis in rats by downregulating expression of angiogenesis‑associated growth factors. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10006
|
| 9 |
Tanyaporn Keratibumrungpong, Warunee Srisuthtayanont, Orawan Wanachewin, Jeerawan Klangjorhor, Thanyaluck Phitak, Peraphan Pothacharoen, Thuzar Hla Shwe, Prachya Kongtawelert. Sesamin Attenuates VEGFA-Induced Angiogenesis via Inhibition of Src and FAK Signaling in Chick Chorioallantoic Membrane Model and Human Endothelial EA.hy926 Cells. Biomedicines 2023; 11(1): 188 doi: 10.3390/biomedicines11010188
|
| 10 |
Qiang Fan, Guangbo Wu, Min Chen, Guqing Luo, Zhenghao Wu, Haizhong Huo, Hongjie Li, Lei Zheng, Meng Luo. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats. European Journal of Pharmacology 2024; 964: 176278 doi: 10.1016/j.ejphar.2023.176278
|
| 11 |
Karn Wijarnpreecha, Fang Li, Yang Xiang, Xun Xu, Cong Zhu, Vahed Maroufy, Qing Wang, Wei Tao, Yifang Dang, Huy Anh Pham, Yujia Zhou, Jianfu Li, Xinyuan Zhang, Hua Xu, C. Burcin Taner, Liu Yang, Cui Tao. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Alimentary Pharmacology & Therapeutics 2021; 54(4): 481 doi: 10.1111/apt.16490
|
| 12 |
Hui Lv, Bo Liu, Yongwen Qin, Md Sayed Ali Sheikh. Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish. Mediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/1958046
|
| 13 |
Peixin Li, Deshu Chen, Yun Cui, Weijin Zhang, Jie Weng, Lei Yu, Lixian Chen, Zhenfeng Chen, Haiying Su, Shengxiang Yu, Jie Wu, Qiaobing Huang, Xiaohua Guo. Src Plays an Important Role in AGE-Induced Endothelial Cell Proliferation, Migration, and Tubulogenesis. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00765
|
| 14 |
Qi Meng, Yi Wang, Tao Yuan, Yang Su, Ziqing Li, Shui Sun. Osteoclast: The novel whistleblower in osteonecrosis of the femoral head. Gene Reports 2023; 33: 101833 doi: 10.1016/j.genrep.2023.101833
|
| 15 |
宇慧 但. Advances in Vascular Endothelial Growth Factor, Interleukin-6 and Homocysteine in Liver Cirrhosis and Gastroesophageal Varices. Advances in Clinical Medicine 2022; 12(02): 1413 doi: 10.12677/ACM.2022.122205
|
| 16 |
Hyun Chang, Sung Hyun Lee. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis. Clinical and Experimental Medicine 2022; 23(3): 853 doi: 10.1007/s10238-022-00842-z
|
| 17 |
Wei‐jin Zhang, Pei‐xin Li, Xiao‐hua Guo, Qiao‐bing Huang. Role of moesin, Src, and ROS in advanced glycation end product‐induced vascular endothelial dysfunction. Microcirculation 2017; 24(3) doi: 10.1111/micc.12358
|
| 18 |
Ismail Erturk, Erdim Sertoglu, Fatih Yesildal, Ramazan Acar, Kenan Saglam, Taner Ozgurtas. Evaluation of plasma VEGF and sVEGFR-1 levels in patients with diabetes mellitus receiving insulin treatment. Turkish Journal of Biochemistry 2019; 44(2): 182 doi: 10.1515/tjb-2017-0348
|
| 19 |
Marina I. Popova, Tatyana A. Kobeleva, Alik I. Sichko. Spectrophotometric analysis of carvedilol in a medication based on aquacomplex of titanium glycerosolvate. Aspirantskiy Vestnik Povolzhiya 2022; 22(2): 67 doi: 10.55531/2072-2354.2022.22.2.67-72
|
| 20 |
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
|
| 21 |
Yan-hui Sun, Xiao-yuan Zhang, Wei-qun Xie, Guang-jian Liu, Xi-xin He, Ya-li Huang, Guang-xian Zhang, Jian Wang, Zao-yuan Kuang, Ren Zhang. Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen. Journal of Ethnopharmacology 2016; 193: 133 doi: 10.1016/j.jep.2016.08.007
|
| 22 |
Laura Turco, Thomas Reiberger, Giovanni Vitale, Vincenzo La Mura. Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension. Liver International 2023; 43(6): 1183 doi: 10.1111/liv.15559
|
| 23 |
Ying Wu, Zhen Li, Sining Wang, Aiyuan Xiu, Chunqing Zhang. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7932046
|
| 24 |
Amr Zidan, Amira A. EL Saadany, Gamal M. El Maghraby, Amany A. Abdin, Sabeha E. Hedya. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice. Toxicology and Applied Pharmacology 2023; 465: 116448 doi: 10.1016/j.taap.2023.116448
|
| 25 |
Qian Ding, Zhen Li, Bin Liu, Liping Ling, Xiangguo Tian, Chunqing Zhang. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway. Human Pathology 2018; 76: 37 doi: 10.1016/j.humpath.2018.02.018
|
| 26 |
Elena I. Lebedeva, Andrei S. Babenka, Anatoly T. Shchastniy. The dynamics of microRNAs level associated with pathological venous angiogenesis in experimental toxic liver fibrosis in rats. Genes & Cells 2024; 19(1): 181 doi: 10.17816/gc622891
|
| 27 |
Shuo Zhang, Li Cai, Hui Zhong, Bo Yang, Weiping Song, Haoyu Jia, Shuai Chen, Fengshang Zhu, Jing Li, Changqing Yang. Prognostic value of virtual portal pressure gradient response in compensated cirrhotic patients treated with carvedilol. Hepatology Research 2024; 54(1): 78 doi: 10.1111/hepr.13963
|
| 28 |
Aline Luciano Horta, Ana Luisa Junqueira Leite, G. Paula Costa, Vivian Paulino Figueiredo, André Talvani. Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruzi. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/9205062
|
| 29 |
Tingting Liu, Fangling Sun, Jiamin Cui, Songyang Zheng, Zijie Li, Deyu Guo, Xin Tian, Zixin Zhu, Wenrong Zheng, Yufeng Wang, Wen Wang. Morroniside enhances angiogenesis and improves cardiac function following acute myocardial infarction in rats. European Journal of Pharmacology 2020; 872: 172954 doi: 10.1016/j.ejphar.2020.172954
|
| 30 |
Jiasheng Deng, Le Qin, Zhipin Zhou. Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon ternifolius (D. Don) Kudo Against Liver Fibrosis. Drug Design, Development and Therapy 2023; : 2335 doi: 10.2147/DDDT.S412818
|
| 31 |
Seul Gi Lee, Jin Soo Kim, Ha-Jeong Kim, David D. Schlaepfer, In-San Kim, Ju-Ock Nam. Endothelial angiogenic activity and adipose angiogenesis is controlled by extracellular matrix protein TGFBI. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88959-1
|
| 32 |
Sarah‐Louise Gillespie, Timothy P. Hanrahan, Don C. Rockey, Avik Majumdar, Peter C. Hayes. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Alimentary Pharmacology & Therapeutics 2023; 57(5): 454 doi: 10.1111/apt.17380
|